Reply: Correspondence on Fluvoxamine Treatment of Patients with Symptomatic COVID-19
10.3947/ic.2022.0045
Author:
Hyeonji SEO
1
;
Yong Pil CHONG
Author Information
1. Division of Infectious Diseases, Department of Internal Medicine, Hallym University Sacred Heart Hospital, Hallym University College of Medicine, Anyang, Korea
Publication Type:Correspondence
From:Infection and Chemotherapy
2022;54(2):370-371